When a patient enters the emergency department presenting with the symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operational outcomes requires fast and accurate chest pain assessment at the point of care, as well as coordination with the laboratory for quality assurance. Having high-sensitivity troponin testing at the point of care—producing accurate results in just 8 minutes—could transform care delivery for millions of people each year, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimising the use of time and resources of busy laboratories.
|
|
|
|
|
|
|
|
|
|
* for hs-cTnI
† This product is under development and not commercially available. Its future availability cannot be ensured.
Sample Types:
|
|
|
|
|
Time to Results~8 minutes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Simple to use and easily integrated into existing systems, the Atellica® VTLi Patient-side Immunoassay Analyzer, powered by Magnotech® Technology, delivers accurate, clinically actionable high-sensitivity troponin I results directly in the hands of those who need it most.
Sample Types:
|
|
|
|
|
Time to Results~8 minutes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service is essential to keep medical equipment operational and safe. Our Nordic service team consists of experienced service technicians stationed across the Nordic countries. Our service technicians are ready to take on your every service need.”
Delivering Confidence and Simplicity during Neuromuscular Blockade
TetraGraph is a quantitative neuromuscular transmission monitor based on electromyography (EMG). The TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents (NMBAs). NMBAs are used in almost 50% of surgical cases. Inadequate reversal of NMBAs can lead to residual neuromuscular blockade (RNMB). RNMB delays recovery and can lead to life-threatening complications. To prevent complications, quantitative neuromuscular monitoring is rapidly becoming the standard of care when NMBAs are administered.
Developmental Care
The fabian +nCPAP evolution is a 3-in-1 device. A therapy system packed in a small yet powerful package, making it ideal for NICU, PICU and transport applications. A true modular system with choice of ventilation modes for the ventilator configuration you need – more can be added and “enabled” whenever desired.
3-in-1
All needed Neonatal and Pediatric conventional ventilation modes, non-invasive ventilation modes and O2 therapy mode with high flow nasal cannula (HFNC) integrated in one device.
Future oriented
Neonatal and Pediatric ventilation modes (IPPV, SIPPV, SIMV, PSV, SIMV+PSV and CPAP), independent adjustment of inspiratory and expiratory flow, reduces the work of breathing and inadvertent PEEP.
Ventilation beyond limits
nCPAP and DuoPAP modes, for nasal ventilation, with leak compensation, featuring two-level CPAP mode to improve CO2 removal.
2-in-1 NIV plus High Flow Nasal Cannula (HFNC)
Fabian Therapy evolution is a 2-in-1 device. It is a small wonder. The fabian Therapy evolution is our NIV dedicated system packed in a small yet powerful package, making it ideal for NICU, PICU and transport applications.
Future-oriented
A wide choice of NIV-ventilation modes for all your needs and compatible with the most popular NIV interfaces available today.
2-in-1
NIV plus High Flow Nasal Cannula (HFNC) available in one device for an easy and safe weaning program.
Ventilation beyond limits
Advanced nCPAP and DuoPAP modes, for nasal ventilation, with automatic leak compensation, two-level CPAP mode improves CO2removal.
Reliable respiration monitoring
The SISS BABYCONTROL monitors respiration of babies and infants and can thus provide reliable assistance against «Sudden Infant Death». High reliability, simple operation and convenient size make the SISS BABYCONTROL® a universally applicable instrument for baby monitoring in hospitals or at home.
Being prepared
Still today, “Sudden Infant Death” is an unforeseeable occurrence. 80% of the affected infants are entirely healthy beforehand. Only 20% are from so-called risk groups (former premature births or babies already suffering from life-threatening conditions or with a «Sudden Infant Death» among close relatives). Only a prompt alarm in the event of irregularities provides the chance to apply life-saving measures within the shortest possible time. Such measures should be learned beforehand in special courses.
Timik ApS
Sivlandvænget 27B, st. th.
5260 Odense S
Tel: +45 8230 6700
Org.nr 36089210
